<?xml version="1.0" encoding="UTF-8"?>
<clinical_study rank="136273">
  <!-- This xml conforms to an XML Schema at:
    http://clinicaltrials.gov/ct2/html/images/info/public.xsd
 and an XML DTD at:
    http://clinicaltrials.gov/ct2/html/images/info/public.dtd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on June 04, 2014</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>http://clinicaltrials.gov/show/NCT02041780</url>
  </required_header>
  <id_info>
    <org_study_id>P120128</org_study_id>
    <nct_id>NCT02041780</nct_id>
  </id_info>
  <brief_title>Non Invasive Assessment of Liver Fibrosis in Children: Comparison of ShearWave Elastography, Fibrotest and Liver Biopsy</brief_title>
  <acronym>SHEARWAVE</acronym>
  <official_title>Non Invasive Assessment of Liver Fibrosis in Children: Evaluation of Diagnostic Performances of ShearWave Elastography (SWE) and Fibrotest®/ Fibromax® by Comparison With Fibrosis Score on Liver Biopsy</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Assistance Publique - Hôpitaux de Paris</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Assistance Publique - Hôpitaux de Paris</source>
  <oversight_info>
    <authority>France: Ministry of Health</authority>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The purpose of this study is to determine if  SWE and Fibrotest®/ Fibromax®, alone or
      associated,  are effective methods to assess liver fibrosis in children.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Liver biopsy will be the gold standard to assess fibrosis using Ishak score and morphometric
      evaluation of fibrosis. All children included will have a measure of liver stiffness using
      SWE  with 5 measures performed in the area where the biopsy is performed and 5 measures in
      an other place in  the liver.  Fibrotest®/ Fibromax® will be performed on blood sample. All
      exams will be done within 1 month. diagnostic performance of SWE and Fibrotest®/ Fibromax®
      will be assessed respectively. algorithm using the results of both technics will be tested
      in order to test diagnostic performance and to obtain better performances.
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date>November 2013</start_date>
  <completion_date type="Anticipated">December 2015</completion_date>
  <primary_completion_date type="Anticipated">November 2015</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <study_design>Endpoint Classification: Efficacy Study, Intervention Model: Single Group Assignment, Masking: Open Label, Primary Purpose: Diagnostic</study_design>
  <primary_outcome>
    <measure>liver fibrosis evaluated by the ISHAK score and morphometric evaluation</measure>
    <time_frame>up to 1 month</time_frame>
    <safety_issue>No</safety_issue>
    <description>Histology is the gold standard to evaluate liver fibrosis</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>liver fibrosis evaluation : stiffness using SHEARWAVE elastography</measure>
    <time_frame>up 1 month</time_frame>
    <safety_issue>No</safety_issue>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Liver fibrosis evaluation using Fibrotest (Fibromax)</measure>
    <time_frame>up 1 month</time_frame>
    <safety_issue>No</safety_issue>
  </secondary_outcome>
  <number_of_arms>1</number_of_arms>
  <enrollment type="Anticipated">80</enrollment>
  <condition>Liver Fibrosis</condition>
  <condition>Children</condition>
  <arm_group>
    <arm_group_label>Population</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Two experimental interventions will be realized in each patient in this population : Shearwave (new diagnostic test of fibrosis) and Fibrotest .
Moreover, liver biopsies, the gold standard for the fibrosis diagnosis is also realized in each patient within usual cares.</description>
  </arm_group>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>Shearwave electrography</intervention_name>
    <arm_group_label>Population</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  age &lt; 18 years;

          -  indication to liver biopsy;

          -  informed consent of both parents and child if applicable;

          -  social insurance

        Exclusion Criteria:

        -
      </textblock>
    </criteria>
    <gender>Both</gender>
    <minimum_age>N/A</minimum_age>
    <maximum_age>18 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Stéphanie FRANCHI-ABELA, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>AP-HP</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Stéphanie FRANCHI_ABELA, MD</last_name>
    <phone>+33 (1) 45 21 31 21</phone>
    <email>stephanie.franchi@bct.aphp.fr</email>
  </overall_contact>
  <location>
    <facility>
      <name>AP-HP, Bicêtre Hospital</name>
      <address>
        <city>Le Kremlin-Bicêtre</city>
        <zip>94275</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Stephanie FRANCHI-ABELA, MD</last_name>
      <phone>+33 (1) 45 21 31 21</phone>
      <email>stephanie.franchi@bct.aphp.fr</email>
    </contact>
  </location>
  <location_countries>
    <country>France</country>
  </location_countries>
  <verification_date>January 2014</verification_date>
  <lastchanged_date>January 20, 2014</lastchanged_date>
  <firstreceived_date>January 20, 2014</firstreceived_date>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>Diagnostic</keyword>
  <keyword>Liver fibrosis</keyword>
  <keyword>Ishak score</keyword>
  <keyword>Fibrotest</keyword>
  <keyword>ShearWave elastography</keyword>
  <keyword>Liver biopsies</keyword>
  <is_fda_regulated>No</is_fda_regulated>
  <has_expanded_access>No</has_expanded_access>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm  -->
    <mesh_term>Fibrosis</mesh_term>
    <mesh_term>Liver Cirrhosis</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                -->
</clinical_study>
